Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Kidney Neoplasms × Diet, Ketogenic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Glioblastoma 8 Neoplasms 3 Endometrial Neoplasms 3 Brain Neoplasms 3 Pancreatic Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Polycystic Ovary Syndrome 1 Pediatric Brain Tumor 1 Ovarian Neoplasms 1 Non-alcoholic Fatty Liver Disease 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Kidney Neoplasms 1 Ketogen-based Therapeutic Diet 1 Head and Neck Neoplasms 1 Growth Hormone-Secreting Pituitary Adenoma 1 Glioma 1 Fatty Liver 1 Estrogen Receptor-positive Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma of Lung 1

Interventions

aldesleukin 37 Sunitinib 34 Cyclophosphamide 27 Nivolumab 25 Interferon-alpha 25 pembrolizumab 24 Everolimus 24 Sorafenib 18 Bevacizumab 18 fludarabine phosphate 17 Interleukin-2 17 Ipilimumab 15 Peripheral Blood Stem Cell Transplantation 14 Filgrastim 14 cabozantinib 13 Gemcitabine 13 Axitinib 13 Radiotherapy 11 temsirolimus 10 fludarabine 10 Radiosurgery 10 Doxorubicin 9 Carboplatin 9 sargramostim 8 belzutifan 8 Fluorouracil 8 Etoposide 8 Chemotherapy, Adjuvant 8 Magnetic Resonance Spectroscopy 7 pazopanib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04316520 2024-08-16

CETOREIN

University Hospital, Angers

Phase NA Completed

Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡